Sanofi-aventis Patient Assistance Program
Sanofi-aventis, makers of Rilutek® (riluzole) tablets, is committed to helping patients
with ALS and their caregivers, and provides them with 2 patient assistance programs:
The Rilutek Continuity Program
- 1-800-RILUTEK
- Provides ALS patients with the following free services:
- Complete pharmacy services.
- Assistance with insurance forms and claims, including job loss
or change.
- Electronic claims processing where permitted by the plan.
- Advocacy if claim is delayed, denied, or sent to a case manager.
- Assistance with accessing federal and state payment programs.
- Referral to the Rilutek Patient Assistance Program.
The Rilutek Patient Assistance Program
- Provides an equal opportunity for ALS patients to receive treatment
- Has helped to cover the cost of Rilutek for hundreds of eligible
patients
- The program is sponsored by sanofi-aventis and is administered
by the National Organization for Rare Disorders (NORD)
- Eligibility is determined solely by medical and financial criteria.
All eligibility decisions are made by NORD
Log onto sanofi-aventis
for more information about the company’s research creativity and innovation in patient
health.